(Q36323149)

13 August 2017

1 reference

title

Myocardial regulatory proteins and heart failure (English)

1 reference

13 August 2017

0 references

Michaela Adamcová

1

1 reference

13 August 2017

Martin Stĕrba

2

1 reference

13 August 2017

Tomás Simůnek

3

1 reference

13 August 2017

Anna Potácová

4

1 reference

13 August 2017

Olga Popelová

5

1 reference

13 August 2017

Vladimír Gersl

6

1 reference

13 August 2017

23 November 2005

1 reference

European Journal of Heart Failure

13 August 2017

1 reference

13 August 2017

8

1 reference

13 August 2017

4

1 reference

13 August 2017

333-342

1 reference

Control of muscle contraction

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin I: inhibitor or facilitator

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Comparison of amino acid sequence of troponin I from different striated muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Structure, function, and regulation of troponin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Structure and regulation of human troponin genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin isoform switching in the developing heart and its functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Role of regulatory proteins (troponin-tropomyosin) in pathologic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Vertebrate tropomyosin: distribution, properties and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Regulatory proteins of the myocardium atrial and ventricular tropomyosin and troponin-I in the developing and adult bovine and human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Comparison of alpha-tropomyosin sequences from smooth and striated muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: physiological and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Requirement of pointed-end capping by tropomodulin to maintain actin filament length in embryonic chick cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Structure and physiological function of calpains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Molecular cloning and expression of chicken cardiac troponin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Molecular cloning of rat cardiac troponin I and analysis of troponin I isoform expression in developing rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin I isoform expression in human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Developmental changes in the expression of rabbit left ventricular troponin T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Identification of and changes in the expression of troponin T isoforms in developing avian and mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Differential expression of TnI and TnT isoforms in rabbit heart during the perinatal period and during cardiovascular stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Re-expression of fetal troponin isoforms in the postinfarction failing heart of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

In vitro motility analysis of thin filaments from failing and non-failing human heart: troponin from failing human hearts induces slower filament sliding and higher Ca(2+) sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Sites phosphorylated in bovine cardiac troponin T and I. Characterization by 31P-NMR spectroscopy and phosphorylation by protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Cardiac troponin I is modified in the myocardium of bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Congenital myopathies: diseases of the actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Role of troponin T in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin T: genetics, properties and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Progress in myocardial damage detection: new biochemical markers for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Myocardial markers of injury. Evolution and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Stretch-induced increase in the Ca2+ sensitivity of myofibrillar ATPase activity in skinned fibres from pig ventricles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Intracellular Na+ activity and positive inotropic effect of sulmazole in guinea pig ventricular myocardium. Comparison with a cardioactive steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Levosimendan improves diastolic and systolic function in failing human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Sustained hemodynamic effects of intravenous levosimendan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Levosimendan: a review of its use in the management of acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

21 January 2018

Heart failure update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Troponin T mRNA and Protein Isoforms in the Human Left Ventricle: Pattern of Expression in Failing and Control Hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.09.007

10.1016/J.EJHEART.2005.09.007

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference